Journal
DRUG DISCOVERY TODAY
Volume 27, Issue 10, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2022.07.006
Keywords
Abridged application; Complex drug delivery system; Extended profiling; Formulation; Market exclusivity; Injection; Risk assessment
Categories
Ask authors/readers for more resources
This review discusses the use of innovative drug delivery systems to improve pain management through the parenteral route. By exploring the latest technologies, the delivery efficiency of drugs can be optimized, and the potential toxicity can be reduced.
Pain is a constant in our lives. The efficacy of drug therapy administered by the parenteral route is often limited either by the physicochemical characteristics of the drug itself or its adsorption-distribution-metabolism-excretion (ADME) mechanisms. One promising alternative is the design of innovative drug delivery systems that can improve the pharmacokinetics vertical bar (PK) and/or reduce the toxicity of traditionally used drugs. In this review, we discuss several products that have been approved by the main regulatory agencies (i.e., nano- and microsystems, implants, and oil-based solutions), highlighting the newest technologies that govern both locally and systemically the delivery of drugs. Finally, we also discuss the risk assessment of the scale-up process required, given the impact that this approach could have on drug manufacturing. Teaser: The management of pain by way of the parenteral route can be improved using complex drug delivery systems (e.g., micro- and nanosystems) which require high-level assessment and shorten the regulatory pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available